Early infliximab trough levels are associated with persistent remission in pediatric patients with inflammatory bowel disease

Namita Singh, Casey J. Rosenthal, Gil Y. Melmed, James Mirocha, Sharmayne Farrior, Silvia Callejas, Bhavna Tripuraneni, Shervin Rabizadeh, Marla C. Dubinsky

Research output: Contribution to journalArticlepeer-review

101 Scopus citations

Fingerprint

Dive into the research topics of 'Early infliximab trough levels are associated with persistent remission in pediatric patients with inflammatory bowel disease'. Together they form a unique fingerprint.

Medicine & Life Sciences